MY187672A - Pharmaceutical preparation for anaesthetic use and associated preparation process - Google Patents
Pharmaceutical preparation for anaesthetic use and associated preparation processInfo
- Publication number
- MY187672A MY187672A MYPI2013700190A MYPI2013700190A MY187672A MY 187672 A MY187672 A MY 187672A MY PI2013700190 A MYPI2013700190 A MY PI2013700190A MY PI2013700190 A MYPI2013700190 A MY PI2013700190A MY 187672 A MY187672 A MY 187672A
- Authority
- MY
- Malaysia
- Prior art keywords
- preparation
- preparation process
- anaesthetic
- propofol
- pharmaceutical preparation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- 230000003444 anaesthetic effect Effects 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940124447 delivery agent Drugs 0.000 abstract 2
- 238000012377 drug delivery Methods 0.000 abstract 2
- 239000007908 nanoemulsion Substances 0.000 abstract 2
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 abstract 2
- 229960004134 propofol Drugs 0.000 abstract 2
- 235000019482 Palm oil Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002540 palm oil Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to the preparation of a nanoemulsion as a carrier or drug delivery agent for propofol, an anaesthetic composition comprising the same and associated methods of preparing the same. In particular, the present invention relates to a palm oil based nanoemulsion as a drug delivery agent for Propofol intended human use, and the associated preparation process.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2013700190A MY187672A (en) | 2013-02-03 | 2013-02-03 | Pharmaceutical preparation for anaesthetic use and associated preparation process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2013700190A MY187672A (en) | 2013-02-03 | 2013-02-03 | Pharmaceutical preparation for anaesthetic use and associated preparation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY187672A true MY187672A (en) | 2021-10-08 |
Family
ID=79185538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2013700190A MY187672A (en) | 2013-02-03 | 2013-02-03 | Pharmaceutical preparation for anaesthetic use and associated preparation process |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY187672A (en) |
-
2013
- 2013-02-03 MY MYPI2013700190A patent/MY187672A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015500115A1 (en) | Glucagon analogues | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| EP3072506A4 (en) | Carrier for drug delivery and conjugate, composition containing same, and method for administering same | |
| MX2016008448A (en) | Var2csa-drug conjugates. | |
| GB201209613D0 (en) | New compounds | |
| EP2927227A4 (en) | Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same | |
| MX366899B (en) | New compounds. | |
| MX2021011906A (en) | Delayed release compositions of linaclotide. | |
| PH12014501991B1 (en) | Phenicol antibacterials | |
| PH12015501982A1 (en) | Pharmaceutical compositions comprising everolimus | |
| TN2014000322A1 (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
| UA116889C2 (en) | COMPOSITION COMPRISING A MIXTURE OF CD95-Fc ISOFORMS | |
| MX2015008021A (en) | Compositions and methods for transdermal delivery of hormones and other medicinal agents. | |
| MX2016004741A (en) | Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent. | |
| MX2014012164A (en) | Compositions containing probiotics and a bee pollen/clay complex, preparation method thereof and uses of same in nutrition and therapeutics. | |
| MX2014004210A (en) | 2-oxo-piperidinyl derivatives. | |
| MX2015003034A (en) | Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, method for the production thereof and use of same. | |
| NZ707636A (en) | Ingenol-derived compounds that can be used for treating cancer | |
| EP4385563A3 (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine | |
| MX2016006738A (en) | Process for producing inorganic particulate material. | |
| MX2015013739A (en) | Glycogen-based water solubility enhancers. | |
| MX367773B (en) | Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof. | |
| MX356102B (en) | Compounds and methods for treating leukemia. | |
| PH12017501979A1 (en) | Pharmaceutical compound | |
| MX2013010947A (en) | Gallium complexes, pharmaceutical compositions and methods of use. |